SlideShare a Scribd company logo
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Kinetic parameters of clonidine hydroxylation in pooled HLM 26 Analyzed   Number of points Km > 0.0 Km   Constraints 2.527 Sy.x 153.3 Absolute Sum of Squares 0.9735 R² 24 Degrees of Freedom   Goodness of Fit 1.577 to 2.508 Km 40.03 to 44.77 Vmax   95% Confidence Intervals 0.2255 Km 1.147 Vmax   Std. Error 2.043 Km 42.40 Vmax   Best-fit values
Screen of 17 common cytochrome P450 isoforms (activity expressed in  pmol/nmol P450/min )
Screen of 17 common cytochrome P450 isoforms (activity expressed in  pmol/nmol P450/min )
 
Kinetic parameters of clonidine hydroxylation in rCYP2D6 26 Analyzed   Number of points Km > 0.0 Km   Constraints 0.9244 Sy.x 20.51 Absolute Sum of Squares 0.9881 R² 24 Degrees of Freedom   Goodness of Fit 8.835 to 11.85 Km 25.00 to 27.15 Vmax   95% Confidence Intervals 0.7314 Km 0.5191 Vmax   Std. Error 10.34 Km 26.07 Vmax   Best-fit values
 
 
 
 
 
[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

study of natural products as leads for new pharmaceuticals for the various cl...
study of natural products as leads for new pharmaceuticals for the various cl...study of natural products as leads for new pharmaceuticals for the various cl...
study of natural products as leads for new pharmaceuticals for the various cl...
Subham Kumar Vishwakarma
 
Antipsychotic agents
Antipsychotic agentsAntipsychotic agents
Antipsychotic agents
Steve Wilkins
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
Jyoti Sharma
 
Prodrug
ProdrugProdrug
2. DRUG DESIGN & RELATION OF FUNCTIONAL GROUPS.pptx
2. DRUG DESIGN & RELATION OF FUNCTIONAL GROUPS.pptx2. DRUG DESIGN & RELATION OF FUNCTIONAL GROUPS.pptx
2. DRUG DESIGN & RELATION OF FUNCTIONAL GROUPS.pptx
ABDULRAUF411
 
Sympathomimetic drugs
Sympathomimetic drugsSympathomimetic drugs
Sympathomimetic drugs
sangeeta dwivedi
 
TITANIUM CHLORIDE.pptx
TITANIUM CHLORIDE.pptxTITANIUM CHLORIDE.pptx
TITANIUM CHLORIDE.pptx
SunnyMaurya19
 
Contraceptive agents (male and female like estradiol,testosterone)
Contraceptive agents (male and female like estradiol,testosterone)Contraceptive agents (male and female like estradiol,testosterone)
Contraceptive agents (male and female like estradiol,testosterone)
Shakir Ali
 
Organic Name Reaction With Their Respective Mechanism
Organic Name Reaction  With Their Respective MechanismOrganic Name Reaction  With Their Respective Mechanism
Organic Name Reaction With Their Respective Mechanism
ASHOK GAUTAM
 
Anticonvulsant
AnticonvulsantAnticonvulsant
Anticonvulsant
Ganesh Andhale
 
Synthetic Reagent and Its Applications (M. Pharm)
Synthetic Reagent and Its Applications (M. Pharm)Synthetic Reagent and Its Applications (M. Pharm)
Synthetic Reagent and Its Applications (M. Pharm)
MohdShafeeque4
 
BROOK REARRANGEMENT
BROOK  REARRANGEMENTBROOK  REARRANGEMENT
BROOK REARRANGEMENT
priyadarshini288
 
Recent advances in neurodegenerative disorders
Recent advances in neurodegenerative disordersRecent advances in neurodegenerative disorders
Recent advances in neurodegenerative disorders
Dr. Siddhartha Dutta
 
Stereochemical aspects
Stereochemical aspectsStereochemical aspects
Stereochemical aspects
MohammadHaider18
 
Medicinal Chemistry of Antihypertensive agents pptx
Medicinal Chemistry of Antihypertensive agents pptxMedicinal Chemistry of Antihypertensive agents pptx
Medicinal Chemistry of Antihypertensive agents pptx
Sameena Ramzan
 
Phosphodiesterase inhibitors
Phosphodiesterase  inhibitorsPhosphodiesterase  inhibitors
Phosphodiesterase inhibitorsElza Emmannual
 
Parasympathomimetics
ParasympathomimeticsParasympathomimetics
Parasympathomimetics
AnkurJoshi62
 
MITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptxMITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptx
TapasMajumder15
 
Chemistry of prostaglandins, leukotrienes and thromboxanes
Chemistry of prostaglandins, leukotrienes and thromboxanesChemistry of prostaglandins, leukotrienes and thromboxanes
Chemistry of prostaglandins, leukotrienes and thromboxanes
Abhimanyu Awasthi
 

What's hot (20)

study of natural products as leads for new pharmaceuticals for the various cl...
study of natural products as leads for new pharmaceuticals for the various cl...study of natural products as leads for new pharmaceuticals for the various cl...
study of natural products as leads for new pharmaceuticals for the various cl...
 
Antipsychotic agents
Antipsychotic agentsAntipsychotic agents
Antipsychotic agents
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
 
Prodrug
ProdrugProdrug
Prodrug
 
2. DRUG DESIGN & RELATION OF FUNCTIONAL GROUPS.pptx
2. DRUG DESIGN & RELATION OF FUNCTIONAL GROUPS.pptx2. DRUG DESIGN & RELATION OF FUNCTIONAL GROUPS.pptx
2. DRUG DESIGN & RELATION OF FUNCTIONAL GROUPS.pptx
 
Sympathomimetic drugs
Sympathomimetic drugsSympathomimetic drugs
Sympathomimetic drugs
 
Drugs and the brain
Drugs and the brainDrugs and the brain
Drugs and the brain
 
TITANIUM CHLORIDE.pptx
TITANIUM CHLORIDE.pptxTITANIUM CHLORIDE.pptx
TITANIUM CHLORIDE.pptx
 
Contraceptive agents (male and female like estradiol,testosterone)
Contraceptive agents (male and female like estradiol,testosterone)Contraceptive agents (male and female like estradiol,testosterone)
Contraceptive agents (male and female like estradiol,testosterone)
 
Organic Name Reaction With Their Respective Mechanism
Organic Name Reaction  With Their Respective MechanismOrganic Name Reaction  With Their Respective Mechanism
Organic Name Reaction With Their Respective Mechanism
 
Anticonvulsant
AnticonvulsantAnticonvulsant
Anticonvulsant
 
Synthetic Reagent and Its Applications (M. Pharm)
Synthetic Reagent and Its Applications (M. Pharm)Synthetic Reagent and Its Applications (M. Pharm)
Synthetic Reagent and Its Applications (M. Pharm)
 
BROOK REARRANGEMENT
BROOK  REARRANGEMENTBROOK  REARRANGEMENT
BROOK REARRANGEMENT
 
Recent advances in neurodegenerative disorders
Recent advances in neurodegenerative disordersRecent advances in neurodegenerative disorders
Recent advances in neurodegenerative disorders
 
Stereochemical aspects
Stereochemical aspectsStereochemical aspects
Stereochemical aspects
 
Medicinal Chemistry of Antihypertensive agents pptx
Medicinal Chemistry of Antihypertensive agents pptxMedicinal Chemistry of Antihypertensive agents pptx
Medicinal Chemistry of Antihypertensive agents pptx
 
Phosphodiesterase inhibitors
Phosphodiesterase  inhibitorsPhosphodiesterase  inhibitors
Phosphodiesterase inhibitors
 
Parasympathomimetics
ParasympathomimeticsParasympathomimetics
Parasympathomimetics
 
MITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptxMITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptx
 
Chemistry of prostaglandins, leukotrienes and thromboxanes
Chemistry of prostaglandins, leukotrienes and thromboxanesChemistry of prostaglandins, leukotrienes and thromboxanes
Chemistry of prostaglandins, leukotrienes and thromboxanes
 

Viewers also liked

Activist Angels - Leadership Development Programme
Activist Angels - Leadership Development ProgrammeActivist Angels - Leadership Development Programme
Activist Angels - Leadership Development Programme
Ogunte CIC
 
Week 6 cyberpolitics
Week 6 cyberpoliticsWeek 6 cyberpolitics
Week 6 cyberpoliticsoiwan
 
受動態(1)
受動態(1)受動態(1)
受動態(1)
shingokeihoku
 
MRLC MR/SR Oct 2016
MRLC MR/SR Oct 2016MRLC MR/SR Oct 2016
MRLC MR/SR Oct 2016
Faye Brownlie
 
Compramos la merienda 2º ciclo 2016
Compramos la merienda 2º ciclo 2016Compramos la merienda 2º ciclo 2016
Compramos la merienda 2º ciclo 2016
XXX XXX
 
Global Conferencing Trends
Global Conferencing TrendsGlobal Conferencing Trends
Global Conferencing Trends
InterCall
 
Ironhack presentation
Ironhack presentationIronhack presentation
Ironhack presentation
pristella84
 
The Seven Deadly Sins of Incentive Compensation
The Seven Deadly Sins of Incentive CompensationThe Seven Deadly Sins of Incentive Compensation
The Seven Deadly Sins of Incentive Compensation
Briscoe Pelkey
 
Michitson inuguration speech for haverhill city council president 010614
Michitson inuguration speech for haverhill city council president 010614Michitson inuguration speech for haverhill city council president 010614
Michitson inuguration speech for haverhill city council president 010614John Michitson
 
Fall Fitness Challenge
Fall Fitness ChallengeFall Fitness Challenge
Fall Fitness ChallengeGreg Cox
 
Social learning circle
Social learning circleSocial learning circle
Social learning circleArie Wels
 
Joe Pollaro Obama look alike
Joe Pollaro Obama look alikeJoe Pollaro Obama look alike
Joe Pollaro Obama look alikeJoe Pollaro
 

Viewers also liked (20)

Activist Angels - Leadership Development Programme
Activist Angels - Leadership Development ProgrammeActivist Angels - Leadership Development Programme
Activist Angels - Leadership Development Programme
 
Sph 107 Ch 8
Sph 107 Ch 8Sph 107 Ch 8
Sph 107 Ch 8
 
Week 6 cyberpolitics
Week 6 cyberpoliticsWeek 6 cyberpolitics
Week 6 cyberpolitics
 
受動態(1)
受動態(1)受動態(1)
受動態(1)
 
MRLC MR/SR Oct 2016
MRLC MR/SR Oct 2016MRLC MR/SR Oct 2016
MRLC MR/SR Oct 2016
 
Compramos la merienda 2º ciclo 2016
Compramos la merienda 2º ciclo 2016Compramos la merienda 2º ciclo 2016
Compramos la merienda 2º ciclo 2016
 
Global Conferencing Trends
Global Conferencing TrendsGlobal Conferencing Trends
Global Conferencing Trends
 
Ironhack presentation
Ironhack presentationIronhack presentation
Ironhack presentation
 
The Seven Deadly Sins of Incentive Compensation
The Seven Deadly Sins of Incentive CompensationThe Seven Deadly Sins of Incentive Compensation
The Seven Deadly Sins of Incentive Compensation
 
Art renaixement
Art renaixementArt renaixement
Art renaixement
 
ikd312-03-design
ikd312-03-designikd312-03-design
ikd312-03-design
 
Michitson inuguration speech for haverhill city council president 010614
Michitson inuguration speech for haverhill city council president 010614Michitson inuguration speech for haverhill city council president 010614
Michitson inuguration speech for haverhill city council president 010614
 
Fall Fitness Challenge
Fall Fitness ChallengeFall Fitness Challenge
Fall Fitness Challenge
 
My Portfolio
My PortfolioMy Portfolio
My Portfolio
 
Social learning circle
Social learning circleSocial learning circle
Social learning circle
 
Sph 106 Ch 15
Sph 106 Ch 15Sph 106 Ch 15
Sph 106 Ch 15
 
7fevrier2009
7fevrier20097fevrier2009
7fevrier2009
 
Joe Pollaro Obama look alike
Joe Pollaro Obama look alikeJoe Pollaro Obama look alike
Joe Pollaro Obama look alike
 
ikh311-08
ikh311-08ikh311-08
ikh311-08
 
Lxb Attest
Lxb AttestLxb Attest
Lxb Attest
 

Similar to In Vitro Metabolism of Clonidine in Human Hepatic Microsomes and Cytochrome P450 Isoforms

Preclinical screening of diuretics.pptx
Preclinical screening of diuretics.pptxPreclinical screening of diuretics.pptx
Preclinical screening of diuretics.pptx
VincyDinakaran
 
Differential metabolic activity and discovery of therapeutic targets using su...
Differential metabolic activity and discovery of therapeutic targets using su...Differential metabolic activity and discovery of therapeutic targets using su...
Differential metabolic activity and discovery of therapeutic targets using su...
Joaquin Dopazo
 
Validated Pain Management Drugs in Urine-MicroLiter
Validated Pain Management Drugs in Urine-MicroLiterValidated Pain Management Drugs in Urine-MicroLiter
Validated Pain Management Drugs in Urine-MicroLiterRick Youngblood
 
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
PerkinElmer, Inc.
 
Renal function tests and intro to urinalysis
Renal function tests and intro to urinalysisRenal function tests and intro to urinalysis
Renal function tests and intro to urinalysis
Princess Alen Aguilar-Cabunoc
 
Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU C...
Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU C...Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU C...
Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU C...
Trustlife
 
LC-MS/MS method for the quantification of carbinoxamine in human plasma
LC-MS/MS method for the quantification of carbinoxamine in human plasmaLC-MS/MS method for the quantification of carbinoxamine in human plasma
LC-MS/MS method for the quantification of carbinoxamine in human plasma
IOSR Journals
 
Transporter activity assays. Fluorescent compounds as replacement for radiola...
Transporter activity assays. Fluorescent compounds as replacement for radiola...Transporter activity assays. Fluorescent compounds as replacement for radiola...
Transporter activity assays. Fluorescent compounds as replacement for radiola...
PRIMACYT Cell Culture Technology GmbH
 
Application of Validated High-performance Liquid Chromatography Method for De...
Application of Validated High-performance Liquid Chromatography Method for De...Application of Validated High-performance Liquid Chromatography Method for De...
Application of Validated High-performance Liquid Chromatography Method for De...
BRNSS Publication Hub
 
Improvement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeImprovement in Protein A Resin Lifetime
Improvement in Protein A Resin Lifetime
Merck Life Sciences
 
Improvement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeImprovement in Protein A Resin Lifetime
Improvement in Protein A Resin Lifetime
MilliporeSigma
 
Method Development and Validation of Tetracycline Antibiotics and their Epime...
Method Development and Validation of Tetracycline Antibiotics and their Epime...Method Development and Validation of Tetracycline Antibiotics and their Epime...
Method Development and Validation of Tetracycline Antibiotics and their Epime...Dr. Mukesh Raikwar
 
Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Rakesh Kumar
 
LCMS-MS Method for Evaluation of PPCPs in Environmental Water
LCMS-MS Method for Evaluation of PPCPs in Environmental WaterLCMS-MS Method for Evaluation of PPCPs in Environmental Water
LCMS-MS Method for Evaluation of PPCPs in Environmental Water
Shimadzu Scientific Instruments
 
Ijpar 1 7
Ijpar 1 7Ijpar 1 7
Ijpar 1 7
pharmaindexing
 
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
SriramNagarajan15
 
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
SriramNagarajan15
 

Similar to In Vitro Metabolism of Clonidine in Human Hepatic Microsomes and Cytochrome P450 Isoforms (20)

Preclinical screening of diuretics.pptx
Preclinical screening of diuretics.pptxPreclinical screening of diuretics.pptx
Preclinical screening of diuretics.pptx
 
Differential metabolic activity and discovery of therapeutic targets using su...
Differential metabolic activity and discovery of therapeutic targets using su...Differential metabolic activity and discovery of therapeutic targets using su...
Differential metabolic activity and discovery of therapeutic targets using su...
 
ruthin 230512
ruthin 230512ruthin 230512
ruthin 230512
 
Validated Pain Management Drugs in Urine-MicroLiter
Validated Pain Management Drugs in Urine-MicroLiterValidated Pain Management Drugs in Urine-MicroLiter
Validated Pain Management Drugs in Urine-MicroLiter
 
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
 
Renal function tests and intro to urinalysis
Renal function tests and intro to urinalysisRenal function tests and intro to urinalysis
Renal function tests and intro to urinalysis
 
Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU C...
Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU C...Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU C...
Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU C...
 
LC-MS/MS method for the quantification of carbinoxamine in human plasma
LC-MS/MS method for the quantification of carbinoxamine in human plasmaLC-MS/MS method for the quantification of carbinoxamine in human plasma
LC-MS/MS method for the quantification of carbinoxamine in human plasma
 
Transporter activity assays. Fluorescent compounds as replacement for radiola...
Transporter activity assays. Fluorescent compounds as replacement for radiola...Transporter activity assays. Fluorescent compounds as replacement for radiola...
Transporter activity assays. Fluorescent compounds as replacement for radiola...
 
Application of Validated High-performance Liquid Chromatography Method for De...
Application of Validated High-performance Liquid Chromatography Method for De...Application of Validated High-performance Liquid Chromatography Method for De...
Application of Validated High-performance Liquid Chromatography Method for De...
 
Improvement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeImprovement in Protein A Resin Lifetime
Improvement in Protein A Resin Lifetime
 
Improvement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeImprovement in Protein A Resin Lifetime
Improvement in Protein A Resin Lifetime
 
Method Development and Validation of Tetracycline Antibiotics and their Epime...
Method Development and Validation of Tetracycline Antibiotics and their Epime...Method Development and Validation of Tetracycline Antibiotics and their Epime...
Method Development and Validation of Tetracycline Antibiotics and their Epime...
 
ANAND PPT
ANAND PPTANAND PPT
ANAND PPT
 
Project ppt
Project pptProject ppt
Project ppt
 
Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)
 
LCMS-MS Method for Evaluation of PPCPs in Environmental Water
LCMS-MS Method for Evaluation of PPCPs in Environmental WaterLCMS-MS Method for Evaluation of PPCPs in Environmental Water
LCMS-MS Method for Evaluation of PPCPs in Environmental Water
 
Ijpar 1 7
Ijpar 1 7Ijpar 1 7
Ijpar 1 7
 
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
 
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...
 

In Vitro Metabolism of Clonidine in Human Hepatic Microsomes and Cytochrome P450 Isoforms

  • 1.
  • 2.
  • 3.  
  • 4. Kinetic parameters of clonidine hydroxylation in pooled HLM 26 Analyzed   Number of points Km > 0.0 Km   Constraints 2.527 Sy.x 153.3 Absolute Sum of Squares 0.9735 R² 24 Degrees of Freedom   Goodness of Fit 1.577 to 2.508 Km 40.03 to 44.77 Vmax   95% Confidence Intervals 0.2255 Km 1.147 Vmax   Std. Error 2.043 Km 42.40 Vmax   Best-fit values
  • 5. Screen of 17 common cytochrome P450 isoforms (activity expressed in pmol/nmol P450/min )
  • 6. Screen of 17 common cytochrome P450 isoforms (activity expressed in pmol/nmol P450/min )
  • 7.  
  • 8. Kinetic parameters of clonidine hydroxylation in rCYP2D6 26 Analyzed   Number of points Km > 0.0 Km   Constraints 0.9244 Sy.x 20.51 Absolute Sum of Squares 0.9881 R² 24 Degrees of Freedom   Goodness of Fit 8.835 to 11.85 Km 25.00 to 27.15 Vmax   95% Confidence Intervals 0.7314 Km 0.5191 Vmax   Std. Error 10.34 Km 26.07 Vmax   Best-fit values
  • 9.  
  • 10.  
  • 11.  
  • 12.  
  • 13.  
  • 14.